EVONIK INDUST.(U.ARD)2 (EVKA) - Total Liabilities
Based on the latest financial reports, EVONIK INDUST.(U.ARD)2 (EVKA) has total liabilities worth €9.81 Billion EUR (≈ $11.47 Billion USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore cash flow conversion of EVONIK INDUST.(U.ARD)2 to assess how effectively this company generates cash.
EVONIK INDUST.(U.ARD)2 - Total Liabilities Trend (2021–2025)
This chart illustrates how EVONIK INDUST.(U.ARD)2's total liabilities have evolved over time, based on quarterly financial data. Check EVONIK INDUST.(U.ARD)2 (EVKA) asset resilience to evaluate the company's liquid asset resilience ratio.
EVONIK INDUST.(U.ARD)2 Competitors by Total Liabilities
The table below lists competitors of EVONIK INDUST.(U.ARD)2 ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Medibank Private Limited
F:MPV
|
Germany | €2.36 Billion |
|
Brown-Forman Corporation
NYSE:BF-B
|
USA | $4.22 Billion |
|
Sunwoda Electronic
SHE:300207
|
China | CN¥67.91 Billion |
|
IDACORP Inc
NYSE:IDA
|
USA | $6.59 Billion |
|
Symbotic Inc
NASDAQ:SYM
|
USA | $2.03 Billion |
|
HYBE Co. Ltd
KO:352820
|
Korea | ₩2.16 Trillion |
|
Qorvo Inc
NASDAQ:QRVO
|
USA | $2.47 Billion |
|
Molson Coors Brewing Co Class B
NYSE:TAP
|
USA | $12.20 Billion |
Liability Composition Analysis (2021–2025)
This chart breaks down EVONIK INDUST.(U.ARD)2's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see EVKA company net worth.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.49 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.21 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.55 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how EVONIK INDUST.(U.ARD)2's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for EVONIK INDUST.(U.ARD)2 (2021–2025)
The table below shows the annual total liabilities of EVONIK INDUST.(U.ARD)2 from 2021 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | €9.81 Billion ≈ $11.47 Billion |
-7.92% |
| 2024-12-31 | €10.65 Billion ≈ $12.45 Billion |
-2.78% |
| 2023-12-31 | €10.95 Billion ≈ $12.81 Billion |
+1.86% |
| 2022-12-31 | €10.75 Billion ≈ $12.57 Billion |
-16.71% |
| 2021-12-31 | €12.91 Billion ≈ $15.10 Billion |
-- |
About EVONIK INDUST.(U.ARD)2
Evonik Industries AG operates as a chemicals company in the Asia-Pacific, Europe, the Middle East, Africa, and the Americas. It operates through the Advanced Technologies, Custom Solutions, and Infrastructure segments. The Advanced Technologies segment provides polymers for medical applications; crosslinkers; hydrogen peroxide, a sterilizing agent for cleaning silicon wafers and a bleaching agent… Read more